Subscribe to Newsletter

Philip J. Rosenfeld

The Power List 2018

Philip J. Rosenfeld

Professor of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA

Philip pioneered the use of Avastin to treat wet AMD. A specialist in vitreoretinal diseases, he theorized, and then proved, that a small amount of the drug, which was approved by the FDA for the treatment of metastatic colorectal cancer, could be injected directly into the eye to help prevent blindness. He determined that this unique therapy was effective in stopping blood vessels from leaking, growing and damaging the retina in the eye. Results of these treatments were remarkable. Not only did Avastin stop further deterioration in vision from wet AMD, but also many patients gained significant improvements in their vision. This discovery has saved vision in millions, has become the standard of care for retina specialists throughout the world for its effectiveness, and has saved healthcare agencies billions of dollars. Philip also developed OCT-guided therapy, which has prevented unneeded injections and, once again, saved healthcare agencies billions of dollars. He has developed numerous algorithms for SD-OCT and SS-OCT imaging that are used in patient care and as endpoints in clinical trials. He has been heavily involved in developing anti-VEGF therapy for wet AMD and is now actively involved in developing novel therapies for dry AMD. He is a Fellowship director who has helped train a generation of medical retina specialists, and an educator and lecturer bringing his expertise and insights to the world of ophthalmology.

Dismiss the Dogma

The Right Design

Part of the Power List 2018

100 reasons to be proud

This is the third time we have tried to map the Top 100 most influential people in the world of ophthalmology. The list includes surgeons, scientists, engineers, CEOs and more, and each one of them has been voted for by you, our readers.

Go to The Power List 2018

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: